1. Home
  2. AADI vs FTCI Comparison

AADI vs FTCI Comparison

Compare AADI & FTCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AADI
  • FTCI
  • Stock Information
  • Founded
  • AADI 2011
  • FTCI 2017
  • Country
  • AADI United States
  • FTCI United States
  • Employees
  • AADI N/A
  • FTCI N/A
  • Industry
  • AADI Biotechnology: Pharmaceutical Preparations
  • FTCI Semiconductors
  • Sector
  • AADI Health Care
  • FTCI Technology
  • Exchange
  • AADI Nasdaq
  • FTCI Nasdaq
  • Market Cap
  • AADI 59.4M
  • FTCI 56.2M
  • IPO Year
  • AADI N/A
  • FTCI 2021
  • Fundamental
  • Price
  • AADI $2.98
  • FTCI $4.10
  • Analyst Decision
  • AADI Hold
  • FTCI Buy
  • Analyst Count
  • AADI 3
  • FTCI 4
  • Target Price
  • AADI $1.75
  • FTCI $8.13
  • AVG Volume (30 Days)
  • AADI 863.3K
  • FTCI 189.1K
  • Earning Date
  • AADI 03-12-2025
  • FTCI 03-12-2025
  • Dividend Yield
  • AADI N/A
  • FTCI N/A
  • EPS Growth
  • AADI N/A
  • FTCI N/A
  • EPS
  • AADI N/A
  • FTCI N/A
  • Revenue
  • AADI $25,070,000.00
  • FTCI $57,354,000.00
  • Revenue This Year
  • AADI $8.43
  • FTCI N/A
  • Revenue Next Year
  • AADI $5.41
  • FTCI $200.01
  • P/E Ratio
  • AADI N/A
  • FTCI N/A
  • Revenue Growth
  • AADI 7.80
  • FTCI N/A
  • 52 Week Low
  • AADI $1.21
  • FTCI $1.76
  • 52 Week High
  • AADI $3.81
  • FTCI $7.40
  • Technical
  • Relative Strength Index (RSI)
  • AADI 50.12
  • FTCI 45.84
  • Support Level
  • AADI $2.91
  • FTCI $3.74
  • Resistance Level
  • AADI $3.27
  • FTCI $6.39
  • Average True Range (ATR)
  • AADI 0.27
  • FTCI 0.77
  • MACD
  • AADI -0.06
  • FTCI -0.13
  • Stochastic Oscillator
  • AADI 11.68
  • FTCI 13.14

About AADI Aadi Bioscience Inc.

Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.

About FTCI FTC Solar Inc.

FTC Solar Inc is a provider of solar tracker systems, supported by proprietary software and value-added engineering services. The company's Solar tracker systems move solar panels throughout the day to maintain an optimal orientation relative to the sun, thereby increasing the amount of solar energy produced at a solar installation. It focuses on providing differentiated products, software, and services that maximize energy generation. The company has launched a new mounting solution to support the installation and use of U.S. manufactured thin-film modules by project owners. The only segment the company is engaged in is the Manufacturing and Servicing of Solar tracker systems.

Share on Social Networks: